Mp. Revuelta et al., TRANSCRIPTIONAL MECHANISMS INVOLVED IN THE RELAXANT EFFECT OF ZERANOLON ISOLATED RAT UTERUS, General pharmacology, 28(4), 1997, pp. 561-565
1. The effect of zeranol (3-100 mu M) on rat uterus contractions induc
ed by KCl (60 mM) and CaCl2 (30 mu M-10 mM) has been assayed. 2. Zeran
ol relaxed the tonic contraction induced by KCl in a concentration-dep
endent manner (IC50 15.62+/-2.66 mu M), CaCl2 (0.1-10 mM) did not coun
teract the relaxing effect of zeranol. 3. CaCl2 (30 mu M-10 mM) produc
ed a concentration-dependent contraction of rat uterus in medium lacki
ng calcium plus KCl (60 mM) (EC(50) 0.34+/-0.03 mM). Zeranol (8 mu M)
displaced the CaCl2 concentration-response curve to the right and incr
eased the EC(50) to 1.27+/-0.57 mM (P<0.05) without modifying the E(ma
x). 4. The antiestrogen tamoxifen (1 mu M) and the inhibitor of cAMP-d
ependent protein kinase TPCK (3 mu M) did not modify the effect of zer
anol. However, the inhibitors of transcription (actinomycin D, 4 mu M)
, protein synthesis (cycloheximide, 100 mu M), and ornithine-decarboxi
lase (alpha-difluoromethyl ornithine, 10 mM)) antagonized the effect o
f zeranol, increasing the IC50 to 50.2+/-6.2 mu M, 122+/-6.9 mu M, and
23.51+/-1.14 mu M, respectively. 5. Our results suggest that the rela
xing effect of zeranol on rat uterus smooth muscle is produced by mech
anisms unrelated to cAMP and estrogen receptors, but involves transcri
ptional effects and polyamine synthesis. (C) 1997 Elsevier Science Inc
.